Skip to content

Feasibility Study of Early Return-home After Colorectal Surgery Using a SENSIUM® Vital Parameter Monitoring Device

Feasibility Study of Early Return-home After Colorectal Surgery Using a SENSIUM® Vital Parameter Monitoring Device

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05610995
Acronym
Colo-SENSIUM
Enrollment
6
Registered
2022-11-09
Start date
2023-07-22
Completion date
2024-10-08
Last updated
2025-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Exit After Colorectal Surgery

Brief summary

The principal aim of this study is to evaluate the impact on length of stay of a return-to-home monitoring device versus enhanced rehabilitation after bowel resection surgery with anastomosis. The device SENSIUM is a tool to monitor vital signs (respiratory rate, heart rate and temperature) by applying a connected skin patch in order to detect complications early.

Interventions

DEVICESENSIUM Patch

The SENSIUM device is a tool to monitor vital signs by applying a connected skin patch whose objective is to detect complications early. The health data is transmitted to the practitioner and in case of disturbance of the parameters, an alert is sent. The patient can be called for consultation or hospitalization if necessary. This device has been tested under real clinical conditions in surgical units. The continuous monitoring of vital signs resulted in earlier detection of sepsis, earlier administration of antibiotics, shorter average length of stay and lower 30-day readmission rates.

Sponsors

University Hospital, Grenoble
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Prospective, multicenter, randomized, two-arm, parallel, open-label, interventional controlled trial with masked outcome assessment (PROBE design)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age ≥ 18 years 2. ASA score 1-3 3. Colonic or rectal resection with anastomosis 4. Minimally invasive surgery 5. Patient living close to the hospital (\<1 hour drive) 6. Patient accompanied for 48 hours 7. Body Mass Index \< 40 8. Patient information and signature of consent 9. Patient affiliated to a social insurance plan 10. A pregnancy test must be performed before inclusion in women of childbearing age. Non-inclusion Criteria: 1. Socially isolated patient and/or no 3G cell signal 2. Severe comorbidities defined as any of these characteristics: 1. Severe malnutrition (albumin \<30g/l) 2. Severe anemia \< 80 g/dl 3. Insulin-dependent diabetes type 1 e. Patient under anticoagulation f. Severe renal insufficiency 3. History of psychiatric illness with medication requirements 4. Persons referred to in articles L1121-5 to L1121-8 of the CSP (corresponds to all protected persons: pregnant women, parturients, nursing mothers, persons deprived of liberty by judicial or administrative decision, persons under legal protection) 5. Patient not wishing to enter the study 6. Patient in a period of exclusion from another study or ongoing participation in an interventional study

Exclusion criteria

1. Stoma preparation 2. Per operative conversion to laparotomy 3. CHUNG score \> 8

Design outcomes

Primary

MeasureTime frameDescription
Evaluating the impact on length of stay of a return-to-home monitoring device versus enhanced rehabilitation after bowel resection surgery with anastomosisat Day 30Overall length of stay of the patient (index stay, and possible re-hospitalizations)

Secondary

MeasureTime frameDescription
Assess painat Day 0, Day 1, Day 2, Day 3, Day 4, Day 5 and Day 30Pain, by visual analog scale (0-10)
Assess opioid useat Day 55-day opioid consumption rate
Evaluate the complication rateat Day 30 according to the postoperative management performedPresence of a complication according to the Clavien Dindo classification
Evaluate the rate of re-hospitalization performedTo the post-surgical hospital discharge at Day 30Presence of a rehospitalization between the post-surgical hospital discharge and Day 30
Assess transit recoveryat Day 1Time of resumption of transit formalized by the resumption of gas, the time being calculated between the closure of the skin and the first gas in hours
Assess the patient's quality of life and overall satisfactionat Day 30EuroQol 5D 3L standardized scale score (overall satisfaction) at pre-inclusion, Day 1, Day 5 and Day 30 post-surgery visit
Evaluate the cost of careTo Day 1 at the end of studyCost analysis (hospitalizations, consultations, re-interventions, time off work, transportation and SENSIUM system costs)
Evaluate the evolution of vital parametersTo Day 1 at the end of studyTrend analysis of vital parameters
Assess the rate of unscheduled visitsat Day 30Presence of an unscheduled consultation at Day 30 post-surgery

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026